Evidence map›Paper›PMID 23782640›Full record

ArticleBMC public health2013

Prevalence and determinants of controlled hypertension in a German population cohort.

Neeltje van den Berg, Claudia Meinke-Franze, Thomas Fiss, Sebastian E Baumeister, Wolfgang Hoffmann

Abstract read
In one paragraph

Article in BMC public health, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. [The hypertensive emergency situation : Recommendations for initial drug therapy management].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2022
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. An Update on Nutrients and Blood Pressure.Journal of atherosclerosis and thrombosis · 2016
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Neeltje van den BergUniversity Medicine Greifswald, Institute for Community Medicine Ellernholzstrasse 1-2, 17487, Greifswald, Germany. neeltje.vandenberg@uni-greifswald.de.
Claudia Meinke-Franze
Thomas Fiss
Sebastian E Baumeister
Wolfgang Hoffmann

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundData of the German population-based cohort SHIP (Study of Health in Pomerania) were analysed to examine treatment rates, antihypertensive substances prescribed, and the proportion of hypertensive study participants reaching target values for blood pressure as well as determinants.

methodsThe study population was defined using baseline data of the cohort (collected between 1997 and 2001). Participants with blood pressure values ≥140/90 mmHg and/or antihypertensive medication with known hypertension and participants with risk-comorbidity (diabetes, stroke, angina pectoris, and/or myocardial infarction) and blood pressure values ≥130/80 mmHg were included. The analysis of treatment and target values was based on the 5-year follow-up of the cohort (collected between 2002 and 2006). Logistic regression was used to identify determinants for a normotensive blood pressure.

results3278 SHIP-participants with hypertensive blood pressure values were included (mean age: 55.5 years; SD 13.6, range 21-80 years). The raw hypertension prevalence was 50.9% (N = 1761). 58.7% (N = 1074) of all hypertensive patients reported some form of antihypertensive treatment. Thereof 65.1% (N = 728) received combination therapy. Of the patients without risk-comorbidity, 42.1% (N = 489) reached their target blood pressure values at the time of the 5-year follow-up of the cohort. Of the patients with any risk-comorbidity this proportion was only 21.7% (N = 131). Significant determinants for reaching the target values were being female and having antihypertensive combination therapy. Increasing age, having risk-comorbidities, and obesity were negatively associated with reaching the target values.

conclusionsBoth the proportion of participants receiving therapy and the number of participants reaching their target blood pressure values are very low. Combination therapy is associated with better blood pressure control as compared to mono therapy. However, even in the subgroup of hypertensive patients under combination therapy only 36% (both patients with and without comorbidity) reach target values.

Indexed as

AdultAgedAged, 80 and overAntihypertensive AgentsBlood PressureCohort StudiesComorbidityDiabetes Mellitus, Type 2EthnicityFemaleGermanyHumansHypertensionLogistic ModelsMaleMiddle AgedAntihypertensive Agents

Identifiers

PMID23782640
PMCPMC3693875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.